Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference5 articles.
1. Committee, W. et al. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play. J. Am. Coll. Cardiol. 79, 1717–1756 (2022). The ACC Expert Consensus Statement on cardiovascular sequelae of COVID-19.
2. Nagel, E., Kwong, R. Y. & Chandrashekhar, Y. S. CMR in nonischemic myocardial inflammation. JACC Cardiovasc. Imaging 13, 163–166 (2020). A recommendation for revising the Lake Louise Criteria, highlighting the unsolved ambiguities of definitions and diagnosis of myocarditis.
3. Hsue, P. Y. & Tawakol, A. Inflammation and fibrosis in HIV. Circ. Cardiovasc. Imaging 9, e004427 (2016). A review article summarizing the link between inflammation, fibrosis and heart failure in people living with human immunodeficiency virus.
4. Kim, C. H. et al. Incidence and risk of heart failure in systemic lupus erythematosus. Heart 103, 227 (2017). A paper reporting a considerable incidence of heart failure in patients with systemic lupus erythematosus.
5. Chang, J. C. et al. A population-based study of risk factors for heart failure in pediatric and adult-onset systemic lupus erythematosus. Semin. Arthritis Rheum. 50, 527–533 (2020). A paper examining risk factors for the high incidence of premature heart failure in a population of patients with systemic lupus erythematosus.